ArticleBMC endocrine disorders2025
Interpretable XGBoost model identifies idiopathic central precocious puberty in girls using four clinical and imaging features.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating Environmental Exposure Profiles with Temporal Transcriptomics: An Explainable Machine Learning Model for Cardiovascular Disease Risk Prediction and Biological Validation.Cardiovascular drugs and therapy · 2026Article
- Development and evaluation of a predictive model for central precocious puberty in girls.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe study aimed to develop interpretable machine learning models for the identification of idiopathic central precocious puberty (ICPP) in girls, without the need for the expensive and time-consuming gonadotropin-releasing hormone (GnRH) stimulation test, which is currently the gold standard for diagnosing ICPP.
methodsA total of 246 female paediatric patients who had secondary sexual characteristics before 8 years old and had taken a GnRH stimulation test were randomly divided into a training set (172 patients, 70%) and a validation set (74 patients, 30%). Characteristic parameters were extracted from easily available clinical data and were statistically analysed. The least absolute shrinkage and selection operator (LASSO) method was used to select essential characteristic parameters associated with ICPP and were used to construct logistic regression (LR) and five machine learning (ML) models, including support vector machine (SVM), Gaussian naive bayes (GaussianNB), extreme gradient boosting (XGBoost), random forest (RF), and k- nearest neighbor algorithm (kNN). Then, the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, false positive and negative values, Youden's index, accuracy, positive and negative likelihood ratios, calibration plots, and decision curve analysis (DCA) were used to evaluate the models' effectiveness. Finally, the shapley additive explanations (SHAP) package was used to interpret the best-performing model.
resultsFour essential characteristic parameters, namely uterine volume, bone age/chronological age (BA/CA), basal follicle-stimulating hormone (FSH), and basal luteinizing hormone (LH), were selected using the LASSO method. Based on these characteristic parameters, the LR and five machine learning models achieved AUC values ranging from 0.72 to 0.96 in the training set and AUC values ranging from 0.65 to 0.90 in the validation set for diagnosing ICPP. Among the LR and five machine learning models, the XGBoost model demonstrated superior performance, achieving the highest AUC values, accuracy, specificity, and sensitivity in both the training and validation sets. Moreover, calibration plots and DCA confirmed that this model exhibited the best calibration and clinical utility.
conclusionsAn accurate and interpretable ML-based model has been developed to aid clinicians in the diagnosis of ICPP, assisting in clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.